Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (281-290 of 430) with videos related to

Pageof 43
Sort By:
Human Molecular Genetics|February 9, 2013
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficitsPatrick J Schultheis, Sheila M Fleming, Amy K Clippinger, et al.
Breast (Edinburgh, Scotland)|May 18, 2026
Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnershipCarsten F J Bakhuis, Anna S Koning, Britt B M Suelmann, et al.
Oncogene|June 6, 2022
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness testsTitia G Meijer, Luan Nguyen, Arne Van Hoeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
PI3K inhibition in combination with tamoxifen in patients with metastatic HR+/HER2- breast cancer: clinical and circulating tumor DNA resultsRosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum, et al.
Nature Communications|February 4, 2018
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancerTesa M Severson, Yongsoo Kim, Stacey E P Joosten, et al.
The Journal of Molecular Diagnostics : JMD|June 8, 2019
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing TechnologyLorenza Mittempergher, Leonie J M J Delahaye, Anke T Witteveen, et al.
The Lancet. Digital Health|December 11, 2025
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancerYoni Schirris, Rosie Voorthuis, Mark Opdam, et al.
International Journal of Cancer|June 5, 2026
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based StudyJoyce Meijer, Nienke Hermanns, Rhodé Bijlsma, et al.
Cancer Cell|September 25, 2020
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER<sup>+</sup> Breast CancerSusana Ros, Alan J Wright, Paula D'Santos, et al.
Contemporary Clinical Trials|July 16, 2017
Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trialT Dahhan, E M E Balkenende, C C M Beerendonk, et al.
Pageof 43

Showing results (281-290 of 430) with videos related to

Sort By:
Pageof 43
Human Molecular Genetics|February 9, 2013
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficitsPatrick J Schultheis, Sheila M Fleming, Amy K Clippinger, et al.
Breast (Edinburgh, Scotland)|May 18, 2026
Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnershipCarsten F J Bakhuis, Anna S Koning, Britt B M Suelmann, et al.
Oncogene|June 6, 2022
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness testsTitia G Meijer, Luan Nguyen, Arne Van Hoeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
PI3K inhibition in combination with tamoxifen in patients with metastatic HR+/HER2- breast cancer: clinical and circulating tumor DNA resultsRosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum, et al.
Nature Communications|February 4, 2018
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancerTesa M Severson, Yongsoo Kim, Stacey E P Joosten, et al.
The Journal of Molecular Diagnostics : JMD|June 8, 2019
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing TechnologyLorenza Mittempergher, Leonie J M J Delahaye, Anke T Witteveen, et al.
The Lancet. Digital Health|December 11, 2025
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancerYoni Schirris, Rosie Voorthuis, Mark Opdam, et al.
International Journal of Cancer|June 5, 2026
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based StudyJoyce Meijer, Nienke Hermanns, Rhodé Bijlsma, et al.
Cancer Cell|September 25, 2020
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER<sup>+</sup> Breast CancerSusana Ros, Alan J Wright, Paula D'Santos, et al.
Contemporary Clinical Trials|July 16, 2017
Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trialT Dahhan, E M E Balkenende, C C M Beerendonk, et al.
Pageof 43